IL1B and Ascites: When the outcome variable was ascites, Model 3, IL‐6 was associated with an increased risk of ascites in the third quartile (Q3) compared with the lowest quartile (Q1) (OR = 3.01, 95% CI = 1.42–6.37, p < .01), the third quartile (Q3) of IL‐10 reflected an increased risk of ascites (OR = 2.57, 95% CI = 1.23–5.37, p < .05), IL‐1β and IL‐8 results were not statistically significant.